Home » Topics » BioWorld Science

BioWorld Science
RSS

Positive phase III results for Aryplase in MPS VI

June 7, 2004

CV Therapeutics and FDA agree on Ranexa study protocol

June 7, 2004

MDI-based insulin regimen is more cost-effective than CSII

June 7, 2004

Successful islet cell transplantation using the Edmonton protocol

June 7, 2004

Wyeth reviews R&D pipeline

June 7, 2004

Latest phase III data on exenatide in type 2 diabetes presented at ADA

June 7, 2004

Tripep receives approval to conduct alphaHGA microdosing study

June 7, 2004

Leptin accelerates wound angiogenesis in vivo

June 7, 2004

Effective wound healing by topical application of novel preclinical therapeutic peptides

June 7, 2004

Nektar Therapeutics reports positive developments on late-stage programs

June 7, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 22, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...